| Bhardwaj, Gunjan (Innoplexus 201107– CEO + Founder before Boston Consulting Group) |
Chief Executive Officer (CEO) |
Innoplexus (Group) |
Germany |
| Bhatia, Dhiren (Viewics 201711 President + Founder) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Bialojan, Siegfried (Ernst & Young) |
Consultant (economic/technology) |
Cap Gemini Ernst & Young (Group) |
Germany |
| Bicker, Uwe (Univ Heidelberg 1983 Professor at Medical Facility + Board Member) |
Professor |
University of Heidelberg (Ruperto Carola) |
Germany |
| Bickert, Stefan (Sensovation 201110 CEO) |
Chief Executive Officer (CEO) |
Miltenyi Biotec (Group) |
Germany |
| Biechl, Susanne (Maisberger 201403 Account Executive) |
Public Relations Manager / Investor Relations Manager |
Maisberger Gesellschaft für strategische Unternehmenskommunikation mbH |
Germany |
| Biegi, Thomas (MorphoSys 202012– Head of Corporate Communications before Pfizer + Daimler) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Bier, Frank F. (Fraunhofer IBMT 200503) |
n. a. |
Fraunhofer (Group) |
Germany |
| Bieri, Christoph (Covalys 200502 CEO) |
Chief Executive Officer (CEO) |
Covalys Biosciences AG |
Switzerland |
| Bigalke, Hans (Toxogen GmbH 201103 Managing Director) |
Managing Director |
Toxogen GmbH |
Germany |
| Bigois, Mathieu (Ponthieu Partners 201702 Founder + European Venture Partner of ABG) |
Partner (venture partner) |
Ponthieu Partners (FR) |
Switzerland |
| Bihlmann, Heike (Swiss Biotech 201105) |
n. a. |
Swiss Biotech Association (SBA) |
Switzerland |
| Bijyohira, Arihiko (Chiome BIoscience 201710 Executive Director + CFO) |
Chief Financial Officer (CFO) |
Chiome Bioscience (Group) |
Japan |
| Bilenker, Josh (Loxo Oncology 201811 CEO) |
Chief Executive Officer (CEO) |
Eli Lilly (Group) |
United States (USA) |
| Bilitewski, U. (Helmholtz 201004 Professor Helmholtz Centre for Infection Research) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Bille, Joachim (Secarna + Genova + Sterna Biologicals 201604 Managing Director) |
Managing Director |
Sterna Biologicals (Genova) (Group) |
Germany |
| Biller, Scott (Foghorn Therapeutics 202001– Board Director before Agios Pharmaceuticals + Novartis + BMS) |
Board member, non-executive |
Foghorn Therapeutics Inc. |
United States (USA) |
| Billert, Thomas (Jena Bioscience 2002 Managing Director (COO) joined in 1999) |
Managing Director |
Jena Bioscience GmbH |
Germany |
| Binaschi, Monica (Menarini 201707) |
n. a. |
Menarini (Group) |
Italy |
| Binder, Josef |
n. a. |
University of Bremen |
Germany |
| Binder, Klaus (Coral BioNet 201107 COO of Scil Technology GmbH) |
Chief Operating Officer (COO) |
Coral BioNet (Group) |
Germany |
| Binder, Veronika (Technoclone 201201 CEO) |
Chief Executive Officer (CEO) |
Technoclone (Group) |
Austria |
| Bindseil, Kai-Uwe (BioTop 200503) |
Cluster Manager |
Berlin (govt region) |
Germany |
| Bingler, Dirk (GUS Group 201706 Managing Director of GUS Deutschland GmbH) |
Managing Director |
GUS Group (Group) |
Germany |
| Biniszkiewicz, Detlev (AstraZeneca 201308 VP Oncology iMed Strategy) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
United Kingdom (GB) |
| Binnema, Doede (Healthy Ageing Network Northern Netherlands 201109 Program Manager Food & Nutrition) |
Cluster Manager |
Healthy Ageing Network Northern Netherlands (HANNN) |
Netherlands |
| Binnig, Gerd (Definiens 201210 CTO + Co-founder + Nobel Laureate) |
Chief Technology/Technical Officer (CTO) |
AstraZeneca (Group) |
Germany |
| Binschek-Domaß, Torsten (Berlin (govt) 201503 Head Clinical + Forensic Toxicology Dept at Labor Berlin) |
President/Director/Head of Research Organisation/Unit |
Berlin (govt region) |
Germany |
| Binz, Thomas (MHH 201504 Researcher at Institute for Physiological Chemistry) |
Researcher (university / research institute) |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Biondi, Paul (Flagship Pioneering 201912– Executive Partner before BMS 2002–2019 most recently SVP Strategy + BusDev) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Birner, Hubert (TVM 200502–200809–) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Birnstiel, Constantin (Merck (DE) 201705– Head of Group Communications before Uniper + Osram + Siemens) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Birr, Christian (Orpegen GmbH 200808 Founder + Managing Director) |
Managing Director |
Orpegen Pharma Gesellschaft für biotechnologische Forschung, Entwicklung & Produktion m.b.H. |
Germany |
| Birrenbach, Iris (bp independent research 200504) |
n. a. |
bp independent research GmbH |
Germany |
| Birsner, Ulrich (GeneScan Europe 200007 CEO) |
Managing Director |
Ava Lifescience GmbH |
Germany |
| Bischof, Matthias (Austria (govt) 201107 Head of Communications at aws) |
Public Relations Manager / Investor Relations Manager |
Austria (govt) |
Austria |
| Bischofberger, Norbert (Kronos Bio 202010 CEO before Gilead Sciences 200903 EVP R&D CSO) |
Chief Executive Officer (CEO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
| Bischoff, Klaus (Merck (D) 200802 Head Performance & Life Science Chemicals division) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Bischoff, Ralf (Pepperprint GmbH 201305 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pepperprint GmbH |
Germany |
| Biselli, Scarlett (Eurofins 201306 Eurofins WEJ Contaminants GmbH) |
n. a. |
Eurofins (Group) |
Germany |
| Bishop, Hans E. (Juno Therapeutics 201601 CEO + Co-Founder before Dendreon + Bayer + GW + SKB) |
Chief Executive Officer (CEO) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Bishop, John L. (Cepheid 200507 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Biskup, Dirk (CeGAT GmbH 200907– Managing Director + founder) |
Managing Director |
CeGaT (Group) |
Germany |
| Biskup, Peer (BayPAT 200807– Managing Director before Innowi GmbH) |
Managing Director |
Universität Bayern e. V. (Uni Bayern e. V.) |
Germany |
| Biskup, Saskia (CeGAT GmbH 200907– Managing Director + founder) |
Managing Director |
CeGaT (Group) |
Germany |
| Bissinger, Michael (Volks- und Raiffeisenbanken 201012 DZ Bank Analyst Healthcare) |
Analyst (Financial / Industry) |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
| Bitter-Suermann, Dieter (Medizinische Hochschule Hannover 200610 President) |
n. a. |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Bittner, Martin-Immanuel (Trinitiy College Oxford + Arctoris Ltd 201901) |
n. a. |
University of Oxford |
United Kingdom (GB) |
| Bitzer, Michael (Univ Tübingen 201009 Professor Univ Hospital Tübingen) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Bizzari, Jean-Pierre (Nordic Nanovector 201605– Board Memeber before Celgene + Sanofi-Aventis) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Bjerke, Torbjørn (Karolinska Institutet 201306 CEO of Karolinska Development before Orexo CEO before Biolipox CEO) |
Chief Executive Officer (CEO) |
Karolinska Development AB (Nasdaq Stockholm: KDEV) |
Sweden |
| Björklund, Håkan (Lundbeck 201310 Board Chairman before Nycomed 1999–2011 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Switzerland |
| Blackman, Lorraine (Rentschler 201911– Head Human Resources at Rentschler Biopharma Inc) |
Human Resources Manager |
Rentschler (Group) |
United States (USA) |
| Blackwell, Chris (Vectura 200504 CEO) |
Chief Executive Officer (CEO) |
Vectura (Group) |
United Kingdom (GB) |
| Blackwell, Kim (Tempus Labs 202009 CMO) |
Chief Medical Officer (CMO) |
Tempus Labs Inc. |
United States (USA) |
| Blain, David (Reinnervate 200709– CFO) |
Chief Financial Officer (CFO) |
ReproCell (Group) |
United Kingdom (GB) |
| Blair, Rainer M. (Danaher 201701 EVP Life Sciences before Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Blanarik, Ivan (Boehringer 201707 SVP + Head Therapeutic Area Biosimilars) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Blanc, Antony (CureVac 202012– CBO + CCO before McKinsey + GSK Vaccines + Synosia + Syngenta) |
Chief Business Officer (CBO) |
CureVac N.V. (Nasdaq: CVAC) |
Netherlands |
| Blank, Michael (Verve Capital Partners 201807 Investment Manager) |
Investment Manager |
Verve Capital Partners AG (investiere.ch) |
Switzerland |
| Blank, Wolfgang (BioCon Valley 201103 Managing Director) |
Managing Director |
BioCon Valley GmbH |
Germany |
| Blanke, Gernot (Blanke Meier Evers + Kompass Private Equity) |
n. a. |
Blanke Meier Evers |
Germany |
| Blankenburg, Axel (Euroimmun 201207 CFO) |
Chief Financial Officer (CFO) |
PerkinElmer (Group) |
Germany |
| Blankenstein, Thomas (Helmholtz 202008 Prof at MDC Berlin + Co-Founder of T-Knife GmbH) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Blasco, María (CNIO 201312 Director) |
President/Director/Head Business Group/Unit/Division |
CNIO (Centro Nacional de Investigaciones Oncológicas) |
Spain (España) |
| Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries) |
Chief Financial Officer (CFO) |
Basilea (Group) |
Switzerland |
| Blaukat, Andree (Merck (DE) 201312 Head Translational Innovation Platform Oncology at Merck Serono) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Blavier, André (Interactive Biosoftware 201211 CEO + Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
France |
| Bléhaut, Jean (Novasep 201509 Chief Innovation Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novasep (Group) |
France |
| Bleiholder, Christian (Florida State Univ 201606 Professor at Dept of Chemistry + Biochemistry) |
Professor |
Florida State University (FSU) |
United States (USA) |
| Bleile, Bernd (Curetis 201602– in-house Legal Counsel) |
Legal Manager |
Curetis (Group) |
Germany |
| Blind, Michael (NascaCell 200809 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Block, Christoph (Signalomics 200604–201307 CEO LEFT 7/13) |
Chief Executive Officer (CEO) |
Signalomics GmbH |
Germany |
| Blome, James A. (Jim) (Cellectis 201810– CEO of Calyxt Inc before Bayer CropScience LP + Valent + Agrliance) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
United States (USA) |
| Bloom, Kenneth (General Electric 201402 CMO of Clarient Diagnostics Services Inc) |
Chief Medical Officer (CMO) |
General Electric (Group) |
United States (USA) |
| Bloomfield, Mark (Polyplus-transfection 201004– CEO before ABI + Thermo Electron + Agilent + HP) |
Chief Executive Officer (CEO) |
Polyplus-transfection (Group) |
France |
| Bluestein, Scott (Hercules Technology 201812 Chief Investment Officer at Hercules Capital) |
Investment Manager |
Hercules Technology Growth Capital Inc. (Nasdaq: HTGC) |
United States (USA) |
| Blumenthal, Ralf (Qiagen 200610 Associate Director BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Blunier, Heinz (Febit 200901– COO before Inventa + Tegimenta + Boehringer Mannheim) |
Chief Operating Officer (COO) |
febit (Group) |
Germany |
| Blöcker, Helmut |
n. a. |
Humangenomprojekt (DE) |
Germany |
| Blöndal, Arni (Brunnur Ventures 201810) |
Investment Manager |
Brunnur Ventures |
Iceland |
| Bobbert, Cornelius |
n. a. |
Kuhnen & Wacker Patent- und Rechtsanwaltsbüro |
Germany |
| Bocci, Marco (Selexis 201311– Director European Sales + Business Development before Quintiles) |
Sales Manager / Marketing Manager |
JSR Corporation (Group) |
Switzerland |
| Boch, Gary (CEVEC Pharmaceuticals 201011 VP BusDev + Head US Business) |
Chief Commercial Officer (CCO) |
Cevec (Group) |
United States (USA) |
| Bochow, Albrecht (GPS Ventures 202012 General Partner) |
General Partner (venture partner) |
GPS Ventures GmbH |
Germany |
| Bochtler, Hans Joachim (MediGene 200809– Head RnD before Fresenius Biotech) |
Research & Development Manager |
Medigene (Group) |
Germany |
| Bock, Holger (Ugichem 201108 Managing Director CEO + founder) |
Managing Director |
Ugichem Gesellschaft für organische Chemie mbH |
Austria |
| Bode, Jörg (Niedersachsen (govt) 200912 Minister of Economic Affairs, Labour and Transport) |
Minister |
Niedersachsen (govt region) |
Germany |
| Bode, Tim (Business Angel) |
n. a. |
PERSON |
|
| Bodenmiller, Bernd (Univ Zurich 201710 Assistant Professor) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Bodiselitsch, Bernd (Imprint Analytics 201812 Managing Director) |
Managing Director |
Imprint Analytics GmbH |
Austria |
| Bodson, Bertrand (Novartis 201801– Chief Digital Officer before Sainsbury’s Argos + EMI + Amazon + Boston Consulting) |
Chief Information Officer (CIO) / Chief Digital Officer |
Novartis (Group) |
Switzerland |
| Boehler, Michael (BioNTech 201905 Head of Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Boehm, Dr. (Heidelberg Pharma 200610 Chief Development Officer) |
Research & Development Manager |
Heidelberg Pharma (Group) |
Germany |
| Boehm, Rainer (Cellectis 201706– Board Member before 29y at Novartis) |
Board member, non-executive |
Cellectis (Group) |
France |
| Boehnlein, Ernst (NascaCell 200708 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee) |
Board member, non-executive |
Boehringer Ingelheim (Group) |
Germany |
| Boehringer, Christoph (Mediatum 2001– Managing Director + CD-Venture 2003– Managing Director + co-owner Boehringer) |
Managing Director |
Mediatum (Group) |
Germany |
| Boehringer, Mathias Albert (Boehringer 200809 Gesellschafterausschuss) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Boeltz, Harry (Dispendix 201812 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellink (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 5 6 7 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
